M&L Healthcare's First MedTech Investment Receives FDA Appro

EQS Newswire / 18/09/2023 / 11:40 CET/CEST SINGAPORE - Media OutReach - 18 September 2023 - M&L Healthcare, in its first major MedTech investment, has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of the LimFlow System - a revolutionary thera...

Related Keywords

United States , Germany , United Kingdom , Changi , Singapore General , Singapore , Paris , France General , France , Steven Kum , Tim Lenihan , Asia Pacific , M Lhealthcare Limflow Medtech , Martin Rothman , Roberto Ferraresi , Jocelyn Kum , Vascular Team In Changi , Rml Group , Limflow Medical Technology , Financial Press , Drug Administration , Limflow System , Chronic Limb Threatening Ischemia , New England Journal , Transcatheter Arterialization , Deep Veins , Chief Medical Officer , Vascular Surgeon , Vascular Team , Changi General Hospital , Executive Director , Deep Venous Arterialization , Crossing Catheters , Breakthrough Designation , Singapore Based Kum , Chief Medical , Financial Press Release , Eqs , Newswire , Et Cest , Media , Outreach , September , M Amp L , Healthcare , , Edtech , Us , Drug , Administration , Limflow , System ,